The invention provides a compound which exhibits satisfactory peroral absorbability and excellent antagonistic activity against NK-1 receptor or NK-2 receptor. The compound is a benzylamine derivative represented by formula (1) or a salt thereof.
本发明提供了一种化合物,该化合物表现出令人满意的口服吸收性以及对NK-1受体或NK-2受体的优异拮抗活性。该化合物是由式(1)表示的苄基胺衍
生物或其盐。